mounjaro is tirzepatide second obesity drug to be approved for use in England | Obesity Mounjaro (Tirzepatide) Injection Pen for

For example, one study revealed that 40% of the weight lost by patients on weekly semaglutide injections came from lean body mass, with about one-third of that being muscle

Long-term STEP Suez data (up to 104 weeks) confirm that semaglutide's safety profile remains stable at maintenance doses when monitored regularly

The company describes this shift as a response to a broader consumer mindset: individuals who have achieved wellness milestones fitness improvements, longevity goals, and weight-loss transformations as a result of the GLP-1 boom now want complementary treatments that help their appearance reflect how they feel

B-cell function was regulated by inhibiting the activation of BAFF receptors, thereby reducing CIA inflammation in mice

This minimizes side effects and is often sufficient for general wellness, anti-aging , and preventative measures